{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:17:42Z","timestamp":1778253462260,"version":"3.51.4"},"reference-count":106,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14824","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T13:09:23Z","timestamp":1732626563000},"source":"Crossref","is-referenced-by-count":8,"title":["Paradigm of biomarkers in metastatic melanoma (Review)"],"prefix":"10.3892","volume":"29","author":[{"given":"Leonel","family":"Pekarek","sequence":"first","affiliation":[{"name":"Department of Medicine and Medical Specialties, Biomedical Network Research Center on Liver and Digestive Diseases, Faculty of Medicine and Health Sciences, University of Alcal\u00e1, 28801 Alcal\u00e1 de Henares, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Cedra","sequence":"additional","affiliation":[{"name":"Oncology Service, University Hospital of Guadalajara, 19002 Guadalajara, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumna Dbouk","family":"Jaudenes","sequence":"additional","affiliation":[{"name":"Oncology Service, University Hospital of Guadalajara, 19002 Guadalajara, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Ospino","sequence":"additional","affiliation":[{"name":"Oncology Service, University Hospital of Guadalajara, 19002 Guadalajara, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Pedrej\u00f3n","sequence":"additional","affiliation":[{"name":"Oncology Service, University Hospital of Guadalajara, 19002 Guadalajara, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loreto","family":"Bernier","sequence":"additional","affiliation":[{"name":"Oncology Service, University Hospital of Guadalajara, 19002 Guadalajara, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo David","family":"Roberts Cervantes","sequence":"additional","affiliation":[{"name":"Oncology Service, University Hospital of Guadalajara, 19002 Guadalajara, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Cendra","sequence":"additional","affiliation":[{"name":"Oncology Service, University Hospital of Guadalajara, 19002 Guadalajara, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Cassinello","sequence":"additional","affiliation":[{"name":"Oncology Service, University Hospital of Guadalajara, 19002 Guadalajara, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"Trasobares","sequence":"additional","affiliation":[{"name":"Department of Medicine and Medical Specialties, Biomedical Network Research Center on Liver and Digestive Diseases, Faculty of Medicine and Health Sciences, University of Alcal\u00e1, 28801 Alcal\u00e1 de Henares, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Quesada\u2011Cort\u00e9s","sequence":"additional","affiliation":[{"name":"Department of Medicine and Medical Specialties, Biomedical Network Research Center on Liver and Digestive Diseases, Faculty of Medicine and Health Sciences, University of Alcal\u00e1, 28801 Alcal\u00e1 de Henares, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"S\u00e1ez","sequence":"additional","affiliation":[{"name":"Department of Medicine and Medical Specialties, Biomedical Network Research Center on Liver and Digestive Diseases, Faculty of Medicine and Health Sciences, University of Alcal\u00e1, 28801 Alcal\u00e1 de Henares, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melchor","family":"\u00c1lvarez\u2011Mon","sequence":"additional","affiliation":[{"name":"Department of Medicine and Medical Specialties, Biomedical Network Research Center on Liver and Digestive Diseases, Faculty of Medicine and Health Sciences, University of Alcal\u00e1, 28801 Alcal\u00e1 de Henares, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Ortega","sequence":"additional","affiliation":[{"name":"Department of Medicine and Medical Specialties, Biomedical Network Research Center on Liver and Digestive Diseases, Faculty of Medicine and Health Sciences, University of Alcal\u00e1, 28801 Alcal\u00e1 de Henares, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"key":"key20241224122958_b1-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global burden of cutaneous melanoma in 2020 and projections to 2040","volume":"158","author":"Arnold","year":"2022","journal-title":"JAMA Dermatol"},{"key":"key20241224122958_b2-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"e2021161S","DOI":"10.5826\/dpc.11S1a161S","article-title":"Epidemiology and risk factors of melanoma: A review","volume":"11","author":"Conforti","year":"2021","journal-title":"Dermatol Pract Concept"},{"key":"key20241224122958_b3-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.cps.2021.05.001","article-title":"Risk factors and prevention of melanoma","volume":"48","author":"Dzwierzynski","year":"2021","journal-title":"Clin Plast Surg"},{"key":"key20241224122958_b4-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"e2245269","DOI":"10.1001\/jamanetworkopen.2022.45269","article-title":"Treatments for melanoma and mortality rate trends in the U.S., 1975 to 2019","volume":"5","author":"Kahlon","year":"2022","journal-title":"JAMA Netw Open"},{"key":"key20241224122958_b5-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00432-023-05533-0","article-title":"Long-term survival of patients with stage IV melanoma: Evaluation of 640 patients with melanoma who entered stage IV between 2014 and 2017","volume":"150","author":"Reitmajer","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20241224122958_b6-ol-29-2-14824","first-page":"63","article-title":"Epidemiology of melanoma","volume":"9","author":"Saginala","year":"2021","journal-title":"Med Sci (Basel)"},{"key":"key20241224122958_b7-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"e397478","DOI":"10.1200\/EDBK_397478","article-title":"Evolution of the treatment of stage IV melanoma","volume":"43","author":"Switzer","year":"2023","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"key20241224122958_b8-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1002\/1878-0261.12732","article-title":"Serum markers improve current prediction of metastasis development in early-stage melanoma patients: A machine learning-based study","volume":"14","author":"Mancuso","year":"2020","journal-title":"Mol Oncol"},{"key":"key20241224122958_b9-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"7478","DOI":"10.1038\/s41598-020-63441-6","article-title":"Predicting circulating biomarker response and its impact on the survival of advanced melanoma patients treated with adjuvant therapy","volume":"10","author":"Irurzun-Arana","year":"2020","journal-title":"Sci Rep"},{"key":"key20241224122958_b10-ol-29-2-14824","first-page":"383","article-title":"Evaluation of biomarkers in melanoma","volume":"4","author":"Karagiannis","year":"2015","journal-title":"Front Oncol"},{"key":"key20241224122958_b11-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3233\/CBM-190370","article-title":"Serological panorama of cytokines in cutaneous melanoma","volume":"26","author":"Paganelli","year":"2019","journal-title":"Cancer Biomark"},{"key":"key20241224122958_b12-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"e0139598","DOI":"10.1371\/journal.pone.0139598","article-title":"Serum IL-10 predicts worse outcome in cancer patients: A meta-analysis","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS One"},{"key":"key20241224122958_b13-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"7614","DOI":"10.18632\/oncotarget.13819","article-title":"Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"key":"key20241224122958_b14-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1158\/1078-0432.CCR-14-1954","article-title":"High serum transforming growth factor-\u03b21 levels predict outcome in hepatocellular carcinoma patients treated with Sorafenib","volume":"15","author":"Lin","year":"2015","journal-title":"Clin Cancer Res"},{"key":"key20241224122958_b15-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0167-4889(00)00098-7","article-title":"Calcium-dependent translocation of S100A11 requires tubulin filaments","volume":"1498","author":"Davey","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"key20241224122958_b16-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/CMR.0b013e32832c6358","article-title":"Expression patterns of S100 proteins in melanocytes and melanocytic lesions","volume":"19","author":"Petersson","year":"2009","journal-title":"Melanoma Res"},{"key":"key20241224122958_b17-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1159\/000155878","article-title":"Baseline staging of melanoma with unknown primary site: The value of serum s100 protein and positron emission tomography","volume":"217","author":"Oberholzer","year":"2008","journal-title":"Dermatology"},{"key":"key20241224122958_b18-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000095034","article-title":"Detection of melanoma relapse: First comparative analysis on imaging techniques versus S100 protein","volume":"213","author":"Beyeler","year":"2006","journal-title":"Dermatology"},{"key":"key20241224122958_b19-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"e242","DOI":"10.1038\/emm.2016.64","article-title":"Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types","volume":"48","author":"Hong","year":"2016","journal-title":"Exp Mol Med"},{"key":"key20241224122958_b20-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.5858\/arpa.2012-0284-OA","article-title":"Marginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas","volume":"137","author":"Viray","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"key20241224122958_b21-ol-29-2-14824","first-page":"13","article-title":"Diagnostic and prognostic biomarkers in melanoma","volume":"7","author":"Weinstein","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"key":"key20241224122958_b22-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.clinbiochem.2004.09.019","article-title":"S100 protein measurement in clinical practice","volume":"38","author":"Dorizzi","year":"2005","journal-title":"Clin Biochem"},{"key":"key20241224122958_b23-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/modpathol.2008.100","article-title":"Nuclear to non-nuclear Pmel17\/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions","volume":"21","author":"Rothberg","year":"2008","journal-title":"Mod Pathol"},{"key":"key20241224122958_b24-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/j.1600-0560.2010.01568.x","article-title":"SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar","volume":"37","author":"Ramos-Herberth","year":"2010","journal-title":"J Cutan Pathol"},{"key":"key20241224122958_b25-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1097\/PAS.0b013e3181658c14","article-title":"Sox10: A pan-schwannian and melanocytic marker","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"key20241224122958_b26-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1309\/MFFF06D5CYXR2F8T","article-title":"Use of Bayes rule and MIB-1 proliferation index to discriminate Spitz nevus from malignant melanoma","volume":"122","author":"Vollmer","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"key20241224122958_b27-ol-29-2-14824","first-page":"300","article-title":"Histopathologic classification and prognostic factors of melanoma: A 2021 update","volume":"156","author":"Bobos","year":"2021","journal-title":"Ital J Dermatol Venerol"},{"key":"key20241224122958_b28-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1093\/annonc\/mdu452","article-title":"PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics","volume":"25","author":"Massi","year":"2014","journal-title":"Ann Oncol"},{"key":"key20241224122958_b29-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/his.12537","article-title":"Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases","volume":"66","author":"Berghoff","year":"2015","journal-title":"Histopathology"},{"key":"key20241224122958_b30-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4103\/idoj.IDOJ_8_18","article-title":"Immunohistochemistry in dermatopathology and its relevance in clinical practice","volume":"9","author":"Chatterjee","year":"2018","journal-title":"Indian Dermatol Online J"},{"key":"key20241224122958_b31-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.3390\/ijms21103535","article-title":"Current molecular markers of melanoma and treatment targets","volume":"21","author":"Yang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"key20241224122958_b32-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"adv00138","DOI":"10.2340\/00015555-3493","article-title":"Melanoma genomics","volume":"100","author":"Newton-Bishop","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"key20241224122958_b33-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/phpp.12329","article-title":"Mechanisms and prevention of UV-induced melanoma","volume":"34","author":"Sample","year":"2018","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"key20241224122958_b34-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"e2308374121","DOI":"10.1073\/pnas.2308374121","article-title":"Photo-neuro-immuno-endocrinology: How the ultraviolet radiation regulates the body, brain, and immune system","volume":"121","author":"Slominski","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20241224122958_b35-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12079-018-0459-1","article-title":"Extracellular matrix regulation of fibroblast function: Redefining our perspective on skin aging","volume":"12","author":"Cole","year":"2018","journal-title":"J Cell Commun Signal"},{"key":"key20241224122958_b36-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/exd.13286","article-title":"UVA-1 exposure in vivo leads to an IL-6 surge within the skin","volume":"26","author":"Schneider","year":"2017","journal-title":"Exp Dermatol"},{"key":"key20241224122958_b37-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"6655","DOI":"10.3390\/ijms23126655","article-title":"Molecular mechanisms of changes in homeostasis of the dermal extracellular matrix: Both involutional and mediated by ultraviolet radiation","volume":"23","author":"Zorina","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key20241224122958_b38-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.maturitas.2011.04.011","article-title":"Molecular aspects of skin ageing","volume":"69","author":"Naylor","year":"2011","journal-title":"Maturitas"},{"key":"key20241224122958_b39-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"7516","DOI":"10.1073\/pnas.89.16.7516","article-title":"Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice","volume":"89","author":"Kripke","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20241224122958_b40-ol-29-2-14824","article-title":"ISSN: 0717-196X theoria@pehuen.chillan.ubiobio.cl","author":"Gonz\u00e1lez-P\u00famariega","year":"2009","journal-title":"Redalyc.org"},{"key":"key20241224122958_b41-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1011-1344(01)00206-8","article-title":"Direct and indirect effects of UV radiation on DNA and its components","volume":"63","author":"Ravanat","year":"2001","journal-title":"J Photochem Photobiol B"},{"key":"key20241224122958_b42-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"842496","DOI":"10.3389\/fonc.2022.842496","article-title":"Melanoma, melanin, and melanogenesis: The Yin and Yang relationship","volume":"12","author":"Slominski","year":"2022","journal-title":"Front Oncol"},{"key":"key20241224122958_b43-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1152\/physrev.00044.2003","article-title":"Melanin pigmentation in mammalian skin and its hormonal regulation","volume":"84","author":"Slominski","year":"2004","journal-title":"Physiol Rev"},{"key":"key20241224122958_b44-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1751-1097.1999.tb07995.x","article-title":"Epidemiological support for an hypothesis for melanoma induction indicating a role for UVA radiation","volume":"70","author":"Moan","year":"1999","journal-title":"Photochem Photobiol"},{"key":"key20241224122958_b45-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nature11624","article-title":"An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair\/fair skin background","volume":"491","author":"Mitra","year":"2012","journal-title":"Nature"},{"key":"key20241224122958_b46-ol-29-2-14824","first-page":"93","article-title":"The chemistry of melanins and melanogenesis","volume":"64","author":"Prota","year":"1995","journal-title":"Fortschr Chem Org Naturst"},{"key":"key20241224122958_b47-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/pcmr.12410","article-title":"Chemical analysis of constitutive pigmentation of human epidermis reveals constant eumelanin to pheomelanin ratio","volume":"28","author":"Del Bino","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"key":"key20241224122958_b48-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/pcmr.12262","article-title":"Pheomelanin-induced oxidative stress: Bright and dark chemistry bridging red hair phenotype and melanoma","volume":"27","author":"Napolitano","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"key20241224122958_b49-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.3390\/biom12121874","article-title":"Melanogenesis and the targeted therapy of melanoma","volume":"12","author":"Li","year":"2022","journal-title":"Biomolecules"},{"key":"key20241224122958_b50-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"500","DOI":"10.5858\/arpa.2019-0561-RA","article-title":"The 2018 World Health Organization classification of cutaneous, mucosal, and uveal melanoma: Detailed analysis of 9 distinct subtypes defined by their evolutionary pathway","volume":"144","author":"Elder","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"key20241224122958_b51-ol-29-2-14824","first-page":"322","article-title":"Genetic markers for characterization and prediction of prognosis of melanoma subtypes: A 2021 update","volume":"156","author":"Podlipnik","year":"2021","journal-title":"Ital J Dermatol Venerol"},{"key":"key20241224122958_b52-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2012.04.025","article-title":"Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness","volume":"324","author":"Comito","year":"2012","journal-title":"Cancer Lett"},{"key":"key20241224122958_b53-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"5384","DOI":"10.3390\/ijms23105384","article-title":"Molecular pathology of skin melanoma: Epidemiology, differential diagnostics, prognosis and therapy prediction","volume":"23","author":"T\u00edm\u00e1r","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key20241224122958_b54-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"25699","DOI":"10.1016\/S0021-9258(18)47305-X","article-title":"Overexpression of mitogen-activated protein kinase kinase (MAPKK) and its mutants in NIH 3T3 cells. Evidence that MAPKK involvement in cellular proliferation is regulated by phosphorylation of serine residues in its kinase subdomains VII and VIII","volume":"269","author":"Seger","year":"1994","journal-title":"J Biol Chem"},{"key":"key20241224122958_b55-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N Engl J Med"},{"key":"key20241224122958_b56-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"e2336","DOI":"10.1097\/MD.0000000000002336","article-title":"GNA11 mutation in a patient with cutaneous origin melanoma: A case report","volume":"95","author":"Patel","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"key20241224122958_b57-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1093\/jnci\/djq363","article-title":"Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study","volume":"102","author":"Demenais","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"key20241224122958_b58-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.0022-202X.2004.23312.x","article-title":"Longitudinal assessment of the nevus phenotype in a melanoma kindred","volume":"123","author":"Florell","year":"2004","journal-title":"J Invest Dermatol"},{"key":"key20241224122958_b59-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"djw135","DOI":"10.1093\/jnci\/djw135","article-title":"Germline CDKN2A mutation status and survival in familial melanoma cases","volume":"108","author":"Helgadottir","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"key20241224122958_b60-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/gcc.22424","article-title":"Germline BAP1 alterations in familial uveal melanoma","volume":"56","author":"Rai","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"key20241224122958_b61-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1210\/endo-108-3-1083","article-title":"1,25-Dihydroxyvitamin D3 and malignant melanoma: The presence of receptors and inhibition of cell growth in culture","volume":"108","author":"Colston","year":"1981","journal-title":"Endocrinology"},{"key":"key20241224122958_b62-ol-29-2-14824","first-page":"2735","article-title":"Decreased VDR expression in cutaneous melanomas as marker of tumor progression: New data and analyses","volume":"34","author":"Bro\u017cyna","year":"2014","journal-title":"Anticancer Res"},{"key":"key20241224122958_b63-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.ejca.2010.01.027","article-title":"MC1R variants increase melanoma risk in families with CDKN2A mutations: A meta-analysis","volume":"46","author":"Fargnoli","year":"2010","journal-title":"Eur J Cancer"},{"key":"key20241224122958_b64-ol-29-2-14824","first-page":"1658","article-title":"Micropthalmia transcription factor (MITF) as a diagnostic marker for metastatic melanomas negative for other melanoma markers","volume":"6","author":"Guo","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"key20241224122958_b65-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1101\/gad.406406","article-title":"Mitf regulation of Dia1 controls melanoma proliferation and invasiveness","volume":"20","author":"Carreira","year":"2006","journal-title":"Genes Dev"},{"key":"key20241224122958_b66-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00018-014-1791-0","article-title":"MITF in melanoma: Mechanisms behind its expression and activity","volume":"72","author":"Hartman","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"key20241224122958_b67-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/jid.2013.293","article-title":"A conditional zebrafish MITF mutation reveals MITF levels are critical for melanoma promotion vs regression in vivo","volume":"134","author":"Lister","year":"2014","journal-title":"J Invest Dermatol"},{"key":"key20241224122958_b68-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"e95157","DOI":"10.1371\/journal.pone.0095157","article-title":"Gene expression profiling identifies microphthalmia-associated transcription factor (MITF) and Dickkopf-1 (DKK1) as regulators of microenvironment-driven alterations in melanoma phenotype","volume":"9","author":"Hartman","year":"2014","journal-title":"PLoS One"},{"key":"key20241224122958_b69-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/nature12688","article-title":"A melanocyte lineage program confers resistance to MAP kinase pathway inhibition","volume":"504","author":"Johannessen","year":"2013","journal-title":"Nature"},{"key":"key20241224122958_b70-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1158\/2159-8290.CD-18-0193","article-title":"Remodeling of the collagen matrix in aging skin promotes melanoma metastasis and affects immune cell motility","volume":"9","author":"Kaur","year":"2019","journal-title":"Cancer Discov"},{"key":"key20241224122958_b71-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/nature17392","article-title":"sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance","volume":"532","author":"Kaur","year":"2016","journal-title":"Nature"},{"key":"key20241224122958_b72-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1038\/ncomms4401","article-title":"Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma","volume":"5","author":"Heidenreich","year":"2014","journal-title":"Nat Commun"},{"key":"key20241224122958_b73-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrc3760","article-title":"Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond","volume":"14","author":"Holderfield","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"key20241224122958_b74-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"key20241224122958_b75-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1158\/1078-0432.CCR-12-0052","article-title":"Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma","volume":"18","author":"Menzies","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20241224122958_b76-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1365-2133.2010.10185.x","article-title":"Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis","volume":"164","author":"Lee","year":"2011","journal-title":"Br J Dermatol"},{"key":"key20241224122958_b77-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1002\/cncr.26724","article-title":"NRAS mutation status is an independent prognostic factor in metastatic melanoma","volume":"118","author":"Jakob","year":"2012","journal-title":"Cancer"},{"key":"key20241224122958_b78-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1001\/jama.2011.746","article-title":"KIT as a therapeutic target in metastatic melanoma","volume":"305","author":"Carvajal","year":"2011","journal-title":"JAMA"},{"key":"key20241224122958_b79-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ad.2017.01.017","article-title":"Novel immunologic approaches to melanoma treatment","volume":"108","author":"Escandell","year":"2017","journal-title":"Actas Dermosifiliogr"},{"key":"key20241224122958_b80-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J Exp Med"},{"key":"key20241224122958_b81-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00262-018-2258-1","article-title":"Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study","volume":"68","author":"Pistillo","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"key20241224122958_b82-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.3390\/cancers16122262","article-title":"Malignant melanoma: An overview, new perspectives, and vitamin D signaling","volume":"16","author":"Slominski","year":"2024","journal-title":"Cancers Basel)"},{"key":"key20241224122958_b83-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2018.03.013","article-title":"Melanoma circulating tumor cells: Benefits and challenges required for clinical application","volume":"424","author":"Marsavela","year":"2018","journal-title":"Cancer Lett"},{"key":"key20241224122958_b84-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3390\/cancers14040859","article-title":"Recent developments of circulating tumor cell analysis for monitoring cutaneous melanoma patients","volume":"14","author":"Shoji","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20241224122958_b85-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41416-020-0750-9","article-title":"Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells","volume":"122","author":"Aya-Bonilla","year":"2020","journal-title":"Br J Cancer"},{"key":"key20241224122958_b86-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1373\/clinchem.2019.307140","article-title":"Prospective molecular profiling of circulating tumor cells from patients with melanoma receiving combinatorial immunotherapy","volume":"66","author":"Lin","year":"2020","journal-title":"Clin Chem"},{"key":"key20241224122958_b87-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"324","DOI":"10.12659\/MSM.904770","article-title":"High number of circulating tumor cells predicts poor survival of cutaneous melanoma patients in China","volume":"24","author":"Li","year":"2018","journal-title":"Med Sci Monit"},{"key":"key20241224122958_b88-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1200\/JCO.1995.13.8.2109","article-title":"Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay","volume":"13","author":"Hoon","year":"1995","journal-title":"J Clin Oncol"},{"key":"key20241224122958_b89-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1158\/1078-0432.CCR-05-1847","article-title":"Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients","volume":"12","author":"Koyanagi","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20241224122958_b90-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1158\/1078-0432.CCR-10-0037","article-title":"Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma","volume":"16","author":"Koyanagi","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key20241224122958_b91-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"2100083","DOI":"10.1002\/anbr.202100083","article-title":"Isolation of circulating tumor cells to diagnose melanoma and evaluate the efficacy of surgical resection using melanoma-specific microsystem","volume":"2","author":"Kang","year":"2022","journal-title":"Adv Nanobiomed Res"},{"key":"key20241224122958_b92-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"key20241224122958_b93-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.omto.2021.05.012","article-title":"Non-coding RNAs in melanoma: Biological functions and potential clinical applications","volume":"22","author":"Peng","year":"2021","journal-title":"Mol Ther Oncolytics"},{"key":"key20241224122958_b94-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jdermsci.2019.11.010","article-title":"MicroRNAs that predict the effectiveness of anti-PD-1 therapies in patients with advanced melanoma","volume":"97","author":"Nakahara","year":"2020","journal-title":"J Dermatol Sci"},{"key":"key20241224122958_b95-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/ncb3399","article-title":"Melanoma miRNA trafficking controls tumour primary niche formation","volume":"18","author":"Dror","year":"2016","journal-title":"Nat Cell Biol"},{"key":"key20241224122958_b96-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1038\/srep02038","article-title":"MiR-21\/Smad 7 signaling determines TGF-\u03b21-induced CAF formation","volume":"3","author":"Li","year":"2013","journal-title":"Sci Rep"},{"key":"key20241224122958_b97-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1158\/0008-5472.CAN-11-1977","article-title":"Tumor suppressive microRNAs miR-34a\/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D","volume":"72","author":"Heinemann","year":"2012","journal-title":"Cancer Res"},{"key":"key20241224122958_b98-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1073\/pnas.0808263106","article-title":"Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor","volume":"106","author":"Segura","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20241224122958_b99-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/pcmr.12379","article-title":"miR-200c\/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment","volume":"28","author":"Liu","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"key":"key20241224122958_b100-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1200\/JCO.21.02229","article-title":"Long-term outcomes with nivolumab plus ipilimumab or nivolumab alone versus ipilimumab in patients with advanced melanoma","volume":"40","author":"Wolchok","year":"2022","journal-title":"J Clin Oncol"},{"key":"key20241224122958_b101-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3390\/biom11111648","article-title":"miRNA as a Modulator of Immunotherapy and Immune Response in Melanoma","volume":"11","author":"Nguyen","year":"2021","journal-title":"Biomolecules"},{"key":"key20241224122958_b102-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3390\/diagnostics13061205","article-title":"MicroRNA-155 and disease-related immunohistochemical parameters in cutaneous melanoma","volume":"13","author":"Fawzy","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"key20241224122958_b103-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1158\/2326-6066.CIR-18-0504","article-title":"MicroRNA-155 expression is enhanced by T-cell receptor stimulation strength and correlates with improved tumor control in melanoma","volume":"7","author":"Martinez-Usatorre","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"key20241224122958_b104-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"14775","DOI":"10.3390\/ijms232314775","article-title":"The roles of miRNAs (MicroRNAs) in melanoma immunotherapy","volume":"23","author":"Dong","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key20241224122958_b105-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.3390\/cancers13092277","article-title":"Neuroendocrine factors in melanoma pathogenesis","volume":"13","author":"Scheau","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key20241224122958_b106-ol-29-2-14824","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.tins.2023.01.003","article-title":"How cancer hijacks the body's homeostasis through the neuroendocrine system","volume":"46","author":"Slominski","year":"2013","journal-title":"Trends Neurosci"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T10:30:06Z","timestamp":1735036206000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":106,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,11,26]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14824","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,26]]},"article-number":"78"}}